GROUP ONE TRADING, L.P. - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$314,565
+53.0%
45,989
+103.1%
0.00%0.0%
Q2 2023$205,553
+252.1%
22,638
+150.5%
0.00%
Q1 2023$58,373
+601.8%
9,036
+588.7%
0.00%
Q4 2022$8,318
-96.3%
1,312
-96.4%
0.00%
Q3 2022$224,000
-24.3%
36,156
+8.0%
0.00%
Q2 2022$296,000
+46.5%
33,473
+39.7%
0.00%
Q1 2022$202,000
-35.7%
23,954
-22.3%
0.00%
Q4 2021$314,000
-9.2%
30,827
+73.1%
0.00%
Q3 2021$346,000
+322.0%
17,806
+280.8%
0.00%
Q2 2021$82,0004,6760.00%
Other shareholders
INMUNE BIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 230,500$2,351,0001.70%
Fermata Advisors, LLC 17,955$183,0000.07%
Virtu Financial LLC 24,364$249,0000.02%
YorkBridge Wealth Partners, LLC 10,369$106,0000.02%
Jump Financial, LLC 21,100$215,0000.01%
Financial Advocates Investment Management 15,167$155,0000.01%
FNY Investment Advisers, LLC 1,100$11,0000.01%
Janney Montgomery Scott LLC 113,914$1,162,0000.01%
Walleye Capital LLC 17,127$175,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 12,473$127,0000.00%
View complete list of INMUNE BIO INC shareholders